Literature DB >> 11092441

Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service.

L Steele1.   

Abstract

Gulf War veterans have reported health problems that they attribute to their military service, but little is understood about the nature or extent of these conditions. To determine whether Kansas Gulf War veterans are affected by excess health problems, a population-based survey of 1,548 veterans who served in the Persian Gulf War (PGW) and 482 veterans who served elsewhere (non-PGW) was conducted in 1998. Gulf War illness, defined as having chronic symptoms in three of six domains, occurred in 34% of PGW veterans, 12% of non-PGW veterans who reported receiving vaccines during the war, and 4% of non-PGW veterans who did not receive vaccines. The prevalence of Gulf War illness was lowest among PGW veterans who served on board ship (21%) and highest among those who were in Iraq and/or Kuwait (42%). Among PGW veterans who served away from battlefield areas, Gulf War illness was least prevalent among those who departed the region prior to the war (9%) and most prevalent among those who departed in June or July of 1991 (41%). Observed patterns suggest that excess morbidity among Gulf War veterans is associated with characteristics of their wartime service, and that vaccines used during the war may be a contributing factor.

Entities:  

Mesh:

Year:  2000        PMID: 11092441     DOI: 10.1093/aje/152.10.992

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  157 in total

Review 1.  Gulf War Illness: Challenges Persist.

Authors:  Mary Nettleman
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

2.  Subcortical brain atrophy in Gulf War Illness.

Authors:  Peka Christova; Lisa M James; Brian E Engdahl; Scott M Lewis; Adam F Carpenter; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2017-06-20       Impact factor: 1.972

3.  Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice.

Authors:  Michael S Petrik; Margaret C Wong; Rena C Tabata; Robert F Garry; Christopher A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

4.  Symptoms and medical conditions in Australian veterans of the 1991 Gulf War: relation to immunisations and other Gulf War exposures.

Authors:  H L Kelsall; M R Sim; A B Forbes; D C Glass; D P McKenzie; J F Ikin; M J Abramson; L Blizzard; P Ittak
Journal:  Occup Environ Med       Date:  2004-12       Impact factor: 4.402

5.  Medical complaints among Iraqi American refugees with mental disorders.

Authors:  Hikmet Jamil; Julie Hakim-Larson; Mohamed Farrag; Talib Kafaji; Laith H Jamil; Adnan Hammad
Journal:  J Immigr Health       Date:  2005-07

6.  Multi-symptom illnesses, unexplained illness and Gulf War Syndrome.

Authors:  Khalida Ismail; Glyn Lewis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

7.  The Association Between Toxic Exposures and Chronic Multisymptom Illness in Veterans of the Wars of Iraq and Afghanistan.

Authors:  Bryann B DeBeer; Dena Davidson; Eric C Meyer; Nathan A Kimbrel; Suzy B Gulliver; Sandra B Morissette
Journal:  J Occup Environ Med       Date:  2017-01       Impact factor: 2.162

8.  Multiple vaccinations, health, and recall bias within UK armed forces deployed to Iraq: cohort study.

Authors:  Dominic Murphy; Matthew Hotopf; Simon Wessely
Journal:  BMJ       Date:  2008-06-30

9.  Effectiveness of nasal irrigation for chronic rhinosinusitis and fatigue in patients with Gulf War illness: protocol for a randomized controlled trial.

Authors:  Supriya D Hayer; David P Rabago; Iliya P Amaza; Tony Kille; Christopher L Coe; Aleksandra Zgierska; Larissa Zakletskaia; Marlon P Mundt; Dean Krahn; Chidi N Obasi; Rachel C Molander
Journal:  Contemp Clin Trials       Date:  2015-01-24       Impact factor: 2.226

10.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.